ATE341311T1 - Selbstemulgierende lipidmatrix (selm) - Google Patents

Selbstemulgierende lipidmatrix (selm)

Info

Publication number
ATE341311T1
ATE341311T1 AT01270324T AT01270324T ATE341311T1 AT E341311 T1 ATE341311 T1 AT E341311T1 AT 01270324 T AT01270324 T AT 01270324T AT 01270324 T AT01270324 T AT 01270324T AT E341311 T1 ATE341311 T1 AT E341311T1
Authority
AT
Austria
Prior art keywords
lipidmatrix
selm
emulsifying
self
emulsifying lipidmatrix
Prior art date
Application number
AT01270324T
Other languages
English (en)
Inventor
Martin Kuentz
Dieter Roethlisberger
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE341311T1 publication Critical patent/ATE341311T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01270324T 2000-12-14 2001-12-08 Selbstemulgierende lipidmatrix (selm) ATE341311T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00127414 2000-12-14

Publications (1)

Publication Number Publication Date
ATE341311T1 true ATE341311T1 (de) 2006-10-15

Family

ID=8170664

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01270324T ATE341311T1 (de) 2000-12-14 2001-12-08 Selbstemulgierende lipidmatrix (selm)

Country Status (17)

Country Link
US (1) US6719996B2 (de)
EP (1) EP1349541B1 (de)
JP (1) JP4116436B2 (de)
KR (1) KR100602299B1 (de)
CN (1) CN1263446C (de)
AR (1) AR032783A1 (de)
AT (1) ATE341311T1 (de)
AU (2) AU2002216085B8 (de)
BR (1) BRPI0116121B8 (de)
CA (1) CA2431397C (de)
DE (1) DE60123661T2 (de)
DK (1) DK1349541T3 (de)
ES (1) ES2272408T3 (de)
MX (1) MXPA03005169A (de)
PT (1) PT1349541E (de)
WO (1) WO2002047663A1 (de)
ZA (1) ZA200304263B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002081A1 (en) * 2000-07-05 2002-01-10 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and methods of using same
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
SE0201922D0 (sv) * 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
CN1984891B (zh) 2004-07-06 2012-08-08 弗·哈夫曼-拉罗切有限公司 用作合成nk-1受体拮抗剂的中间体的甲酰胺吡啶衍生物的制备方法
KR20070094666A (ko) 2005-02-25 2007-09-20 에프. 호프만-라 로슈 아게 약제 물질 분산성이 향상된 정제
EP1959926A1 (de) * 2005-10-25 2008-08-27 Abbott Laboratories Formulierung mit einem arzneimittel geringer wasserlöslichkeit und anwendungsverfahren
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
US20090011079A1 (en) * 2007-07-02 2009-01-08 Bestsweet, Inc. Hard Coated Confectionary Having A Consumable Soft Chewing Core With An Active And Method For Making Same
ES2623503T3 (es) 2009-11-18 2017-07-11 Helsinn Healthcare Sa Composiciones para tratar náuseas y vómitos mediados centralmente
EP2722045B1 (de) 2009-11-18 2016-07-06 Helsinn Healthcare SA Zusammensetzungen zur Behandlung von zentral vermitteltem Unwohlsein und Erbrechen
CN105412110B (zh) 2011-10-18 2018-05-25 赫尔森保健股份公司 奈妥匹坦和帕洛诺司琼的治疗性组合
US8426450B1 (en) 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
US20180042259A1 (en) * 2015-02-26 2018-02-15 The Nisshin Oillio Group, Ltd. Powdered fat composition for chocolate
CA2996717A1 (en) 2015-09-11 2017-03-16 Chase Pharmaceuticals Corporation Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system
IL312486B2 (en) 2017-04-10 2025-05-01 Chase Therapeutics Corp NK1 antagonist combination and method for treating synucleinopathies
CA3104811C (en) 2017-06-30 2024-05-28 Chase Therapeutics Corporation Composition comprising pramipexole and nk1-antagonists for treating depression
CN109200018A (zh) * 2017-07-04 2019-01-15 南京诺瑞特医药科技有限公司 含有奈妥吡坦的微乳制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
PT1035115E (pt) * 1999-02-24 2005-01-31 Hoffmann La Roche Derivados de 4-fenilpiridina e a sua utilizacao como antagonistas do receptor nk-1
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same

Also Published As

Publication number Publication date
KR20030062423A (ko) 2003-07-25
CN1263446C (zh) 2006-07-12
PT1349541E (pt) 2007-01-31
AU2002216085B2 (en) 2005-11-03
US6719996B2 (en) 2004-04-13
AU1608502A (en) 2002-06-24
CA2431397A1 (en) 2002-06-20
JP2004517837A (ja) 2004-06-17
BRPI0116121B8 (pt) 2021-05-25
CN1514720A (zh) 2004-07-21
MXPA03005169A (es) 2003-09-22
ZA200304263B (en) 2004-03-26
KR100602299B1 (ko) 2006-07-14
EP1349541B1 (de) 2006-10-04
CA2431397C (en) 2007-05-01
EP1349541A1 (de) 2003-10-08
US20020114837A1 (en) 2002-08-22
DK1349541T3 (da) 2007-01-08
DE60123661T2 (de) 2007-08-16
BRPI0116121B1 (pt) 2015-07-14
ES2272408T3 (es) 2007-05-01
BR0116121A (pt) 2003-10-14
WO2002047663A1 (en) 2002-06-20
JP4116436B2 (ja) 2008-07-09
AU2002216085B8 (en) 2006-03-02
AR032783A1 (es) 2003-11-26
DE60123661D1 (de) 2006-11-16

Similar Documents

Publication Publication Date Title
DK1303496T3 (da) Pyrimidinderivater
DE60131628D1 (de) Stenteinführvorrichtung
DE60140253D1 (de) Oreinheit
DK1889838T3 (da) Thrombopoietin-mimetika
EP1289601A4 (de) Elektropankreatographie
DK1250154T3 (da) G-CSF-konjugater
DE60113491D1 (de) Nassbehanlungsvorrichtung
DE60134208D1 (de) Nkkommunikationsverfahren
DE60112442D1 (de) Luftführungsprüfgerät
DE60132558D1 (de) Renozeptorantagonisten
DE60104308D1 (de) Rekonfigurationsverwalter
DE60128494D1 (de) Wachstumhormonsekretionsförderer
DE60119505D1 (de) Kraftstoffschlauch
DE60142951D1 (de) Evakuationssystem
ATE341311T1 (de) Selbstemulgierende lipidmatrix (selm)
DE60131191D1 (de) Hautdurchdringungsgaskollektor
DE60102473D1 (de) Indolochinazolinone
DE60114748D1 (de) Reibschweissverbinden
DE60111752D1 (de) 7-oxopyridoryrimidine
DE60103268D1 (de) Hochdruckumformspülanlage
DE60101130D1 (de) Düftungsgerät
DE60134773D1 (de) Allringen
FI20011324A0 (fi) Monitoimielin
NO20032291D0 (no) Pyrimidinderivater
DE50113112D1 (de) Schaltungsanordnung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1349541

Country of ref document: EP